Active, not recruiting
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
NCT06223568
- Conditions
- Cancer Vaccine, Carcinoma, Carcinoma, Squamous Cell, +16 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States